
David H Ciocon, MD
About Me
Dr. David Ciocon received his undergraduate degree from Harvard University (cum laude) and his M.D. from UMDNJ-New Jersey Medical School, where he was elected to the Alpha Omega Alpha Honor Society. Prior to his residency in dermatology, he completed three years of a combined general and plastic surgery residency training at Brown University, Rhode Island Hospital as well as a one-year clinical research fellowship in psoriasis at Harvard University, Brigham & Women’s Hospital. He subsequently completed his dermatology residency at the Albert Einstein College of Medicine, Montefiore Medical Center, where he was Chief Resident and recipient of the Leo M. Davidoff Award for Excellence in Teaching. He then completed a Mohs Micrographic Surgery and Procedural Dermatology fellowship at Skin Laser & Surgery Specialists of New York and New Jersey under the guidance of Dr. David Goldberg. He has co-authored numerous articles and chapters in the fields of psoriasis, nail disorders, and surgical and non-surgical approaches to cosmetic rejuvenation.
A board certified dermatologist, Dr. Ciocon is licensed in New Jersey and New York. He is a member of the American Society for Dermatologic Surgery and the American Academy of Dermatology. He is also a member the American College of Mohs Surgery and Cutaneous Oncology. . He is currently the Director of Mohs Micrographic Surgery and Procedural Dermatology at the Montefiore Medical Center, Albert Einstein College of Medicine. Dr. Ciocon is on the medical staff of Englewood Hospital and Medical Center in New Jersey and Montefiore Medical Center and Mount Sinai Medical Center in New York. His clinical interests include Mohs Micrographic surgery, facial reconstructive and aesthetic surgery, laser-assisted tumescent liposuction, autologous fat transfer, laser medicine, and minimally invasive cosmetic dermatology.
Language
English
Position
CLINICAL INSTRUCTOR | Dermatology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ciocon has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.